Clinical trial
Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors
NCT02257476
Study timeline
Study start (actual)2014-08-01Date precision: month
Registry last updated2017-02-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasmsunresolved
Malignanciesunresolved
Interventions
CarfilzomibDRUG · verified · RxNorm: carfilzomib
DexamethasoneDRUG · verified · RxNorm: dexamethasone
Sponsors & collaborators
Emory Universitylead sponsor
Amgencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02257476 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.